284 related articles for article (PubMed ID: 19262989)
1. Killer B lymphocytes: the evidence and the potential.
Lundy SK
Inflamm Res; 2009 Jul; 58(7):345-57. PubMed ID: 19262989
[TBL] [Abstract][Full Text] [Related]
2. Characterization and activity of Fas ligand producing CD5⁺ B cells.
Lundy SK; Klinker MW
Methods Mol Biol; 2014; 1190():81-102. PubMed ID: 25015275
[TBL] [Abstract][Full Text] [Related]
3. Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes.
Lundy SK; Taitano SH; van der Vlugt LEPM
Methods Mol Biol; 2021; 2270():149-178. PubMed ID: 33479898
[TBL] [Abstract][Full Text] [Related]
4. Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.
Lundy SK; Fox DA
Arthritis Res Ther; 2009; 11(4):R128. PubMed ID: 19706160
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.
Lundy SK; Boros DL
Infect Immun; 2002 Feb; 70(2):812-9. PubMed ID: 11796615
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10.
Klinker MW; Reed TJ; Fox DA; Lundy SK
PLoS One; 2013; 8(8):e70131. PubMed ID: 23940537
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of immune suppression by B lymphocytes.
Klinker MW; Lundy SK
Mol Med; 2012 Feb; 18(1):123-37. PubMed ID: 22033729
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.
Ju ST; Matsui K; Ozdemirli M
Int Rev Immunol; 1999; 18(5-6):485-513. PubMed ID: 10672498
[TBL] [Abstract][Full Text] [Related]
9. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
10. Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.
Mabrouk I; Buart S; Hasmim M; Michiels C; Connault E; Opolon P; Chiocchia G; Lévi-Strauss M; Chouaib S; Karray S
Immunity; 2008 Dec; 29(6):922-33. PubMed ID: 19013083
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
[TBL] [Abstract][Full Text] [Related]
12. Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load.
Eiza N; Zuckerman E; Carlebach M; Rainis T; Goldberg Y; Vadasz Z
Clin Exp Immunol; 2018 Aug; 193(2):183-193. PubMed ID: 29665000
[TBL] [Abstract][Full Text] [Related]
13. Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse.
Okazaki A; Hiraga N; Imamura M; Hayes CN; Tsuge M; Takahashi S; Aikata H; Abe H; Miki D; Ochi H; Tateno C; Yoshizato K; Ohdan H; Chayama K
Hepatology; 2012 Aug; 56(2):555-66. PubMed ID: 22331638
[TBL] [Abstract][Full Text] [Related]
14. Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand.
Ols ML; Cullen JL; Turqueti-Neves A; Giles J; Shlomchik MJ
Immunity; 2016 Nov; 45(5):1052-1065. PubMed ID: 27793595
[TBL] [Abstract][Full Text] [Related]
15. Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse.
Lee J; Dieckmann NMG; Edgar JR; Griffiths GM; Siegel RM
Immun Inflamm Dis; 2018 Jun; 6(2):312-321. PubMed ID: 29642281
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
[TBL] [Abstract][Full Text] [Related]
17. TLR4 supports the expansion of FasL
Wang K; Tao L; Su J; Zhang Y; Zou B; Wang Y; Zou M; Chen N; Lei L; Li X
Mol Immunol; 2017 Jul; 87():188-199. PubMed ID: 28505514
[TBL] [Abstract][Full Text] [Related]
18. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
19. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.
Truman JP; Choqueux C; Tschopp J; Vedrenne J; Le Deist F; Charron D; Mooney N
Blood; 1997 Mar; 89(6):1996-2007. PubMed ID: 9058721
[TBL] [Abstract][Full Text] [Related]
20. Activated B cells express functional Fas ligand.
Hahne M; Renno T; Schroeter M; Irmler M; French L; Bornard T; MacDonald HR; Tschopp J
Eur J Immunol; 1996 Mar; 26(3):721-4. PubMed ID: 8605944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
